ALAN COLOWICK
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
RANA AL-HALLAQ, RAKHSHITA DHAR, JULIA EASTLAND, KOUKI HARASAKI, EDWARD HURWITZ, ARTHUR E JOHNSON, HELEN KIM, HELEN S. KIM, DAVID LOCKHART, DAVID J LOCKHART, DAVID J. LOCKHART, PATRICIA MILLICAN, TRISHA MILLICAN, DEAN MITCHELL, OLEG NODELMAN, INAI PARK, RA SESSION II, SHEHNAAZ SULIMAN, PETER THOMPSON, PETER A. THOMPSON, MICHAEL TORRES, BASHEER ZADA
DIRECTOR
DIRECTOR
PATRICK BAEUERLE, JOSEPH BAILES, PABLO CAGNONI, MARK CHIN, JONATHAN DRACHMAN, JULIE EASTLAND, GEORGIA L. ERBEZ, LUKE EVNIN, DAN HICKLIN, RON HUNT, RONALD HUNT, GERALD MCMAHON, SCOTT MYERS, WILLIAM E. PICHT, ANDREW ROBBINS, NATALIE R. SACKS, LAUREN SILVERNAIL, LAUREN P. SILVERNAIL, JOANNE VINEY, LUKE WALKER, LUKE NATHANIEL WALKER, HOLGER WESCHE
DIRECTOR
SRINIVAS AKKARAJU, MARTIN BABLER, VIKRAM BAJAJ, JULIAN BAKER, MARK BRADLEY, ALAN B. COLOWICK, JORN DRAPPA, RICHARD GASTER, DAVID M. GOLDSTEIN, ROY C. HARDIMAN, SARA KLEIN, JUNE LEE, PATRICK MACHADO, DERRICK RICHARDSON, MICHAEL ROME, JOHN R. SCHROER, SAPNA SRIVASTAVA, SAPNA B. SRIVASTAVA, JAMES TANANBAUM, JAMES B. TANANBAUM, ZHENGBIN YAO
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$25,000,001 - $100,000,000
Equity
2023-03-23
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-08-16

